Childhood brain tumors: current management, biological insights, and future directions: JNSPG 75th Anniversary Invited Review Article
IF Pollack, S Agnihotri, A Broniscer - Journal of Neurosurgery: Pediatrics, 2019 - thejns.org
Brain tumors are the most common solid tumors in children, and, unfortunately, many
subtypes continue to have a suboptimal long-term outcome. During the last several years …
subtypes continue to have a suboptimal long-term outcome. During the last several years …
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
J Fangusaro, O Witt, PH Driever, AK Bag… - The lancet …, 2020 - thelancet.com
Paediatric low-grade gliomas (also known as pLGG) are the most common type of CNS
tumours in children. In general, paediatric low-grade gliomas show clinical and biological …
tumours in children. In general, paediatric low-grade gliomas show clinical and biological …
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
AS Guerreiro Stucklin, S Ryall, K Fukuoka… - Nature …, 2019 - nature.com
Infant gliomas have paradoxical clinical behavior compared to those in children and adults:
low-grade tumors have a higher mortality rate, while high-grade tumors have a better …
low-grade tumors have a higher mortality rate, while high-grade tumors have a better …
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas
R Sigaud, TK Albert, C Hess, T Hielscher… - Nature …, 2023 - nature.com
Pediatric low-grade gliomas (pLGG) show heterogeneous responses to MAPK inhibitors
(MAPKi) in clinical trials. Thus, more complex stratification biomarkers are needed to identify …
(MAPKi) in clinical trials. Thus, more complex stratification biomarkers are needed to identify …
[HTML][HTML] Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
ASG Stucklin, S Ryall, K Fukuoka… - Nature …, 2019 - ncbi.nlm.nih.gov
Infant gliomas have paradoxical clinical behavior compared to those in children and adults:
low-grade tumors have a higher mortality rate, while high-grade tumors have a better …
low-grade tumors have a higher mortality rate, while high-grade tumors have a better …
FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation–Positive Low-Grade Glioma
MI Barbato, J Nashed, D Bradford, Y Ren… - Clinical Cancer …, 2024 - AACR
Abstract On March 16, 2023, the FDA approved dabrafenib in combination with trametinib
(Tafinlar, Mekinist; Novartis Pharmaceuticals Corporation) for the treatment of pediatric …
(Tafinlar, Mekinist; Novartis Pharmaceuticals Corporation) for the treatment of pediatric …
Vincristine in combination therapy of cancer: emerging trends in clinics
J Škubník, VS Pavlíčková, T Ruml, S Rimpelová - Biology, 2021 - mdpi.com
Simple Summary Vincristine is a vinca alkaloid naturally occurring in Catharanthus roseus. It
belongs to antimitotic compounds, which arrest the cell cycle via disrupting microtubule …
belongs to antimitotic compounds, which arrest the cell cycle via disrupting microtubule …
Response to trametinib treatment in progressive pediatric low-grade glioma patients
F Selt, CM van Tilburg, B Bison, P Sievers… - Journal of Neuro …, 2020 - Springer
Introduction A hallmark of pediatric low-grade glioma (pLGG) is aberrant signaling of the
mitogen activated protein kinase (MAPK) pathway. Hence, inhibition of MAPK signaling …
mitogen activated protein kinase (MAPK) pathway. Hence, inhibition of MAPK signaling …
Management of pediatric low-grade glioma
P De Blank, P Bandopadhayay… - Current opinion in …, 2019 - journals.lww.com
Management of pediatric low-grade glioma : Current Opinion in Pediatrics Management of
pediatric low-grade glioma : Current Opinion in Pediatrics Log in or Register Subscribe to …
pediatric low-grade glioma : Current Opinion in Pediatrics Log in or Register Subscribe to …
EANO-EURACAN-SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors
R Rudà, D Capper, AD Waldman, J Pallud… - Neuro …, 2022 - academic.oup.com
In the new WHO 2021 Classification of CNS Tumors the chapter “Circumscribed astrocytic
gliomas, glioneuronal and neuronal tumors” encompasses several different rare tumor …
gliomas, glioneuronal and neuronal tumors” encompasses several different rare tumor …